July 31, 2013 / 6:48 AM / 4 years ago

Spain's Grifols H1 net profit up 37 pct

MADRID, July 31 (Reuters) - Spanish pharmaceutical company Grifols, the world’s third-largest blood products maker, said on Wednesday net profit rose 37 percent in the first half from a year earlier to 182.8 million euros ($242 million), boosted by overseas sales, especially in the United States.

Barcelona-based Grifols, which generates over 90 percent of its sales outside its recession-hit home market, said first half revenue was 1.38 billion euros, up 4.9 percent from the same period last year. ($1 = 0.7547 euros) (Reporting by Julien Toyer; Editing by Sonya Dowsett)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below